NIKITA PRYOR: Open Payments
NPI 1427757368 · BARTLETT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,225 in 164 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $1,925 · 2025 $3,225
Food & beverage: $3,225
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $671 |
| GENZYME CORPORATION | 10 | $335 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $209 |
| PFIZER INC. | 15 | $207 |
| Madrigal Pharmaceuticals | 8 | $187 |
| Janssen Biotech, Inc. | 9 | $184 |
| Gilead Sciences, Inc. | 9 | $176 |
| Ardelyx, Inc. | 11 | $175 |
| Phathom Pharmaceuticals, Inc. | 5 | $171 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $168 |
Products named: DUPIXENT, RINVOQ, LINZESS, REZDIFFRA, TREMFYA, IBSRELA, VOQUEZNA, XIFAXAN.
Industry payments across TN — which companies pay providers there.
